NKO Covered by European Patent

LAVAL, Quebec Neptune Technologies & Bioressources Inc. received a European use patent, Krill Extracts for Prevention and/or Treatment of Cardiovascular Diseases. Additionally, in mid-October, the companys Neptune Krill Oil (NKO®) was officially approved by the European Food Safety Authority (EFSA) as a Novel Food and PARNUTS for immediate commercialization in the European Union.

According to Tina Sampalis, Ph.D., Neptunes chief scientific officer, the combination of the patent and the EFSA approval should combine to strategically pursue the use of krill oil for heart health in Europe. Wael Massrieh, director of R&D at Neptune, added, Being patent protected and the pioneer at penetrating the European market is a strategically significant accomplishment, allowing Neptune to pursue this market in an open field. The company also stated its intention to address situations of patent infringement or products sold without regulatory approval to protect its commercial position.